Shang Lin to Antibodies, Monoclonal
This is a "connection" page, showing publications Shang Lin has written about Antibodies, Monoclonal.
Connection Strength
0.055
-
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence. Leuk Lymphoma. 2009 Nov; 50(11):1809-17.
Score: 0.055